Member Info for poole

Hello Stuartrm, It took me almost an hour to carefully read through the RNS announcement - I think the reduction in adjusted EPS is mainly due to the losses in the medical division as it is primed for early commercialisation of both the scanning technology products. As for the share price there ought ti be genuine serious buyers around hoping to hoover up sellers concerned of possible budgets changes affecting CGT or Inheritance Tax.

Hi, doze .

I like your phrase 'Talk the Torque'

Hope that the share price also continues to do the taiking!

Am wondering if the recent activity and upward movement in the share price ahead of this announcement reflected some investors getting foreknowledge ?

I have no shareholding in this but have been following messages posted for some time.

VALSEN seems both in JULY & AUGUST to have repeated his somewhat earlier observations as to real issues as if they still represented the current situation. Given the RNS announcement today 12th Aug that would not appear to be the present situation which suggests that the management believes it has got a hold on things! If that is the case then there would appear to be a positive future for investors at the current share price..

First bought this stock October 2013 at the equivalent of 400p per share -that was followed by years of price falling to around 40p.

Subsequently held-off buying until adding stock substantially at circa 70p around September 2022 - pleased to see that the present price is the highest it has been in the past 5 years.

ANY ONE KNOW WHY THE BUYING INTEREST TODAY - ALREADY 78 TRADES?

Last year on 11th April 2023 there was a Q1 2023 Update - why no update on Q1 2024 so far this year'

The Q1 Update last year was followed on 9th June 2023 by the Audited Results for FY 2022.

Has anyone had contact with the company of there brokers for news as to when to expect the Audited Results for 2023.

I AGREE-steady as she goes!

Positive movement accompanied by a decent supply of stock should give encouragement to potential larger buyers . On the way, but may take a couple more years to deliver results what they should be capable of and a somewhat higher share price that reflects the turn-around by then in their fortunes. Meantime , hopefully no more dilution for existing holders from giving away shares at the current level.

Very welcome news to me, as I had been wondering who had been driving the share price down of late with regular sells. This may not stop them but there should be some new converts as to the outlook for SAW looking to get on board for the ride.

Following an event organised by Hardman in conjunction with Surface Transforms around 20th April 2023 participants were asked for Feedback which I readily supplied by email after being asked to highlight in ‘bold type’ questions I particularly wanted answered. I highlighted Q2 to Q6.

See below

I don’t recall getting any comprehensive response!

------ Original Message ------

From: "Events"

To “Poole”

Sent: Friday, 21 Apr, 23 At 12:18

Subject: RE: FEEDBACK ON THE SURFACE TRANSFORMS EVENT?

Dear “Poole”

My apologies on the feedback form. Please find the questions below. If you would like to respond I will collate the feedback with the rest of the responses.

Regarding the questions, please highlight any below you want further details on and I pass this on to the team.

Many thanks

Alona

My questions

Q1 Re: Operational Management. You say intending to recruit a person for the new position of Chief Operating Officer reporting directly to the CEO . Any update on making a permanent appointment? Meantime you have made an interim appointment. What are the professional qualifications of the interim appointee?

Q2 How many professionally qualified Chemical Engineers do we employ?

Q3 You have separately been advertising for a ‘Six Sigma Project Manager’. Who will they be reporting to?

Q4 It is not clear what adding each ‘new cell’ consists of? Is it principally an extra furnace or is it a complete suite of Stages 1 through to Stage 10 as shown on your web site?

Q5 (a)As an attendee last year at one of your shareholder events at Knowsley I understood that the new furnaces (Stage 3) represented a major change in the manufacturing process. In the light of recent events even before the introduction of additional cells (now due Q2 2023) there needs to be clarification as to what changes that involved.

At that Knowsley event last year, I had anticipating possible issues with making a major process change asked whether pre-testing off site was to take place. From recollection I got a short non-answer reply. Perhaps I should have been more insistent as it now appears that ought to have been undertaken. Why wasn’t it? (b)Surely if done properly it would before going live have revealed the flue lining failure rate as unacceptable.

Q6 I have also recently questioned without as yet a response whether the process diagram of Stage 3 on your website as shown would provide for stable resilient production. Does it adequately convey the processes to be undertaken at the heart of the new cells furnaces?

Pokerchips very recent comments (why suddenly no longer shown!) & those of Fevertreeman remain on the ball.

When I last commented in mid-February I said' I live in hope that they have or will very soon iron out the production problems'

I had sensed for some time that there was a lot of scrappage going on -realistically that can only have arisen in either Stages 3 (Chemical Vapour Infiltration(CVIST)) or 4 (Hear Treatment) of the manufacturing process as detailed by the company online. The company refers in communications to 'Furnaces' only with regard to Stage 4(Hear Treatment)!

My suspicion is that the principal problem area is & has been Stage 3 albeit not described online as a furnace. I maybe wrong but from the start that Stage as detailed online looks to lack suitable controls that would ensure uniformity of product through put - and hence potentially much scrappage . As to the extent of Q1 2024 scrappage is all very vague (as usual) -the amount of extra working capital (? twixt £1.5m & £2m)that ZEUS refer to in their paid for research might suggest that scrappage even exceeded acceptable production! Did it?

Frankly I have doubts as to whether the Stage 3 process as detailed online by the company is how it is now organised!

ZEUS state ' ....that in recent weeks their has been considerable success(!) achieved in recent weeks in reducing scrap' . No explanation as to how or where that has been achieved.

Pleased to see that the Chairman will be leaving -the sooner the better. He clearly did not protect shareholders by asking at the outset the right questions about the process changes as to testing & implementation that have led to the serious problems. As for the CEO he did a good job in getting potential customers on board but must hold responsibility for the production mess we got into as a result of not suitably testing and seeing the major process change was feasible and capable of working before committing us to it. He probably needs to go too.

In my last post I said that the dolling out of huge number of new share options at such a depressed share price was a disgrace -it felt like robbery.

!

HELLO REGARDING TRUTH FACTORY'S- LAST POST

- please what is the relevance of the word 'Avid' in relation to TRT's new MD.

What is 'Avid' & what damage is being referred to??

There are seldom any messages here.

Any thoughts as to why the AMS share price has suddenly fallen about 15% -is the Peters Surgical deal seen as that bad?

Initial reaction to prelims & deal appeared to be positive. Where has the selling come from?

BGF/Pershing continue to add to their large holding- now over 14%- the 200k trade at 35p late on 5th March not reported until the next day reflects the 200k increase in their holding since their recent disclosure . The two largest shareholders between them now appear to hold 29.5% of the equity. It should not be too long before we get to see the preliminary results for 2023 with an update on both their cost reduction programme and progress in consolidating their databases that will facilitate their marketing of applications involving the use of Artificial Intelligence(AI).

When I posted recently I suggested that Ebiquity was around two-thirds of the way trough their cost reduction program it is probably more like half way through, and that BGF Investment Management Limited (on behalf of Pershing Securities Limited) with now around 13.9% of the equity was the largest shareholder. That is not yet the case as when last disclosed in early December 2023 Canaccord Genuity Wealth Management (with 21,793,566 shares) held 15.52% versus BGF Investment Management Limited's 10.02%. I suspect that there may be further interest from BGF/Pershing but perhaps biding their time at present! Still would be interested to know where BGF/Pershing's recent purchases came from. For me Artificial Intelligence with their own huge data bases is the future for EBQ. I would like to see them saying more to patient shareholders about those opportunities.

Further to my recent post there has been a disclosure notification by BGF Investment Management Ltd on behalf of shareholder Pershing.Securities Limited. Having recently added nearly 3% to their holding they are now with 13.9% the largest shareholder. More modest buying since then appears to be by others. Will be interesting to see where this takes the share price.. No indication yet in form of a disclose if needed as to where the bulk of BGF's additional stock came from.

WONDERING IF SOMEONE KNOWS SOMETHING. In recent days there appears to be persistent buyers both before and after some unusually large trades. No notifications yet! What are we to make of this? Incidentally, they must by now be almost two thirds of the way through their strategic move to take out over 3 years circa £5m of their cost base probably largely related to reorganising their data bases - this is likely at some stage soon to be augmented by moves to incorporate AI into their product offerings Is this what keen buyers have their eye on?

I live in hope that they have or will very soon iron out the production problems. A few months back there was a suggestion that there were teething issues in several areas tha were being attended to. That was largely a red herring.

I still think that the real issue is do they have the main furnace problem solved? Otherwise they need to let us know how they are able to forward order for further furnaces required?

As to their recently dolling out huge numbers of options at the very depressed they have caused it was a disgrace. The go ahead for the new options was given by shareholders when the share price was closer to 50p!

To me shareholders are being robbed.

How on earth the two main shareholders have continued to put up with this also needs some explaining - I have to agree with most of what "fevetreeman" has to say. The Chairman's job is too look after shareholders interest by asking the right questions which he appears not to have being for several years now. As for Johnson he failed to see that the major process change was feasible and capable of working before committing us to it. Enough said

Hello, upward movement in the shares today suggests maybe a tip - any thoughts as too the source?

Having recently added a few shares to my holding was pleased to see the appointment of a Sales Director to beef up their Translogic business unit where their product portfolio is now well placed to gain impetus under his leadership. Surprised that this announcement has not yet produced more buyers at this level.

Noticed lot of small transactions early this morning - has the share been tipped over the weekend?